UG
UG
NASDAQ · Consumer products

United Guardian Inc

$7.15
+0.00 (+0.00%)
As of Feb 8, 2:22 PM ET ·
UG News7 articles
UnitedHealth Gains Amid Market Rout as Medicare Advantage Deadlines Loom
UnitedHealth shares advanced nearly 2% on Thursday, defying a broad market decline, as attention turned to key Medicare Advantage policy deadlines and a profit warning from peer Humana.
Markets 2d ago
JetBlue and United Launch Cross-Booking Platform Under Blue Sky Alliance
JetBlue and United Airlines have activated reciprocal flight sales on their digital platforms, allowing customers to book eligible routes across both networks using cash or loyalty currencies.
Markets 4d ago
UnitedHealth Gains Amid Medicare Rate Uncertainty and ACA Investigations
UnitedHealth shares edged higher as investors monitored upcoming Medicare Advantage payment decisions and a House Republican probe into ACA insurers. The sector traded mixed.
Regulation 5d ago
UnitedHealth Dips After Hours as Medicare Rate Decision Looms
UnitedHealth shares edged lower in extended trading Monday as healthcare stocks underperformed the broader market. Investors are focused on upcoming Medicare Advantage reimbursement updates, with the final rates expected in early April.
Markets 5d ago
UnitedHealth Shares Edge Higher Amid Medicare Rate Scrutiny and Broader Market Volatility
UnitedHealth Group stock rose slightly as investors assessed a modest proposed Medicare Advantage payment increase for 2027. The healthcare giant continues to navigate pressure following a significant revenue warning earlier this year.
Markets 6d ago
UnitedHealth Rallies 3% to Close Volatile Week; Medicare Advantage Outlook in Focus
UnitedHealth shares gained 3% Friday to $276.65, stabilizing after a turbulent period for managed-care stocks. Investors now await earnings from CVS Health and Humana next week for critical updates on Medicare Advantage trends.
Markets 6d ago
UnitedHealth Rebounds 3% as Managed Care Sector Weighs Diverging Cost Outlooks
UnitedHealth shares rose 3% to $276.65 Friday, recovering after Molina Healthcare's weak 2026 forecast pressured the sector. Investors now await Humana's results and a key Medicare Advantage rate decision.
Markets Feb 7